Literature DB >> 24909297

Should we recommend neuroaminidase inhibitors for influenza?

L Leibovici1, M Paul.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24909297     DOI: 10.1111/1469-0691.12708

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  4 in total

1.  Predictors of viral pneumonia in patients with community-acquired pneumonia.

Authors:  Ji Eun Kim; Uh Jin Kim; Hee Kyung Kim; Soo Kyung Cho; Joon Hwan An; Seung-Ji Kang; Kyung-Hwa Park; Sook-In Jung; Hee-Chang Jang
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

2.  Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data.

Authors:  Martin Wolkewitz; Martin Schumacher
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

3.  Is there a clinical difference between influenza A and B virus infections in hospitalized patients? : Results after routine polymerase chain reaction point-of-care testing in the emergency room from 2017/2018.

Authors:  Mario Karolyi; Erich Pawelka; Simon Daller; Caroline Kaczmarek; Hermann Laferl; Iulia Niculescu; Birte Schrader; Christian Stütz; Alexander Zoufaly; Christoph Wenisch
Journal:  Wien Klin Wochenschr       Date:  2019-06-18       Impact factor: 1.704

4.  Antiviral activity of an aqueous extract derived from Aloe arborescens Mill. against a broad panel of viruses causing infections of the upper respiratory tract.

Authors:  B Glatthaar-Saalmüller; A M Fal; K Schönknecht; F Conrad; H Sievers; A Saalmüller
Journal:  Phytomedicine       Date:  2015-07-02       Impact factor: 5.340

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.